Back
Freeport-McMoRan Vs. Janux Therapeutics Industry Stock Comparison
Buy
67
FCX
Freeport-McMoRan
Last Price:
54.85
Seasonality Move:
2.09%
Sell
37
JANX
Janux Therapeutics
Last Price:
47.99
Seasonality Move:
8.69%
Buy
67
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
- The current Freeport-McMoRan [FCX] share price is $54.23. The Score for FCX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.10. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $54.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.10
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
FCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 64.29 | Buy |
| Chaikin Money Flow: | 15610253 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.03 - 52.25) | Buy |
| Bollinger Bands (100): | (38.73 - 49.21) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | -317532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.78 - 57.84) | Sell |
| Bollinger Bands (100): | (12.31 - 49.41) | Buy |
FCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.25 | Buy |
| 20-day SMA: | 50.85 | Buy |
| 50-day SMA: | 48.47 | Buy |
| 200-day SMA: | 40.9 | Buy |
| 8-day EMA: | 52.52 | Buy |
| 20-day EMA: | 51.21 | Buy |
| 50-day EMA: | 48.45 | Buy |
| 200-day EMA: | 42.59 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.54 | Sell |
| 20-day SMA: | 52.99 | Sell |
| 50-day SMA: | 45.97 | Buy |
| 200-day SMA: | 20.17 | Buy |
| 8-day EMA: | 49.81 | Sell |
| 20-day EMA: | 50.9 | Sell |
| 50-day EMA: | 45.06 | Buy |
| 200-day EMA: | 26.54 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.08 per share, an increase this year of $0.04 per share, and an increase next year of $0.61 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Freeport-McMoRan Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||